PRE-CLOSE TRADING UPDATE
13 December 2005
Bodycote International plc, the leading materials services company, is issuing
this regular trading update prior to entering the close period ahead of its
full year results for the year ending 31 December 2005.
HIGHLIGHTS
The Board expects to announce full-year sales and operating profit in line with
the consensus of analysts' forecasts for the Group.
Sales growth for the year to date (at constant exchange rates) has been 9%, of
which 4% is from acquisitions and 5% is organic. Acquisitions completed during
the year are expected to contribute approximately £18m in sales in 2005 and £
32m in a full year.
Energy costs have continued to increase and are being largely passed on to
customers, although the recovery lag is typically several months.
The execution of the Group's strategy of expanding the Testing business and to
widen the geographic coverage of Heat Treatment and HIP remains firmly on
track.
GROUP
At the time of the interim results announcement we reported that first half
sales, for the continuing business at constant exchange rates, were 8% higher
than in the same period last year at £229.3m and operating profit (excluding
impairment of goodwill and restructuring costs) was ₤29.2m compared to ₤22.3m
in the first half of 2004, an increase of 31%. Organic growth in the second
half has been almost 5% compared to approximately 6% in the first half, with
the reduction primarily due to softer than expected demand from continental
European automotive customers. Demand from the aerospace, power generation, oil
& gas and health science sectors are buoyant but prospects for the automotive
sector remain uncertain.
The most notable increases in energy costs have been in North America, in the
immediate aftermath of the two Gulf Coast hurricanes, where prices are still
60% above pre hurricane levels, and in the UK, where wholesale gas prices have
increased significantly. These cost increases continue to be largely passed on
to customers although recovery often lags by several months.
We continue to progress the geographic expansion of the Group's network of
facilities. Three bolt-on acquisitions have been completed since the interim
results announcement. Two are Testing laboratories namely Food Products
Laboratory Inc, in Portland, Oregon USA, which complements our UK and Canadian
food testing businesses, and Arthur Gordon Environmental Evaluators Limited
based in Montreal, Canada, who carry out continuous monitoring of emissions for
customers in the paper, metallurgy and petrochemical industries and supports
Bodycote's existing stack sampling business in Quebec City. The Group has also
acquired the heat treatment operations of UTTIS Industries SA, which have been
combined with our existing business in Romania. A number of other potential
acquisitions are at various stages of evaluation and negotiation and several of
these are expected to complete early in the New Year.
The impact of exchange rates on currency translation of the Group's sales and
profits has been immaterial.
Cash generation remains strong as a result of continued tight control of
capital expenditure, and the ongoing focus on working capital management.
STRATEGIC BUSINESS UNIT (SBU) OVERVIEW
Heat Treatment sales in local currency are cumulatively running more than 6%
ahead of last year, of which three quarters is organic and operating profit is
up 14%. Turnover has increased in all geographies, although slower automotive
demand has held back Germany and France. Product mix in North America and
France together with energy cost increases in most countries remain the biggest
challenges in improving profitability.
Metallurgical Coatings is performing satisfactorily.
Testing continues to be the best performing SBU with sales, at constant
exchange rates, 28% up on last year of which 9% is organic and 19% from
acquisitions, but operating margins, as anticipated, are slightly lower and in
line with the first half. The division has recorded strong organic growth in
all regions, but with the benefit of acquisitions, total sales increase has
been largest in the UK and continental Europe.
Hot Isostatic Pressing is maintaining its improved performance, with sales more
than 8% (in local currency) higher year to date than 2004, as a result of
strong demand for aerospace and industrial gas turbine components together with
our Densal® programme for high performance automotive castings.
The Preliminary Results will be announced on 28 February 2006.
An investor and analyst conference call is taking place today, 13 December, at
10:00 hours (GMT).
The dial-in number is +44 (0) 845 146 2010 password is Bodycote
For further information, please contact:
Bodycote International plc Tel No: +44 (0)1625 505300
John D. Hubbard, Chief Executive
David Landless, Group Finance Director
Financial Dynamics Tel No: +44 (0) 20 7831 3113
Jon Simmons
Sally Lewis
AI Summary Disclaimer BETA
The content you are viewing has been generated or assisted by artificial
intelligence (AI). While efforts are made to ensure accuracy and clarity, AI-generated text may
contain inaccuracies, outdated information, or subjective interpretations. This content is intended
for general informational purposes only and should not be considered professional advice or factual
confirmation.
We encourage you to independently verify any information provided,
especially if it will be relied upon for making decisions or taking action. Any reliance you place
on this material is strictly at your own risk. The AI system that produced this content cannot
assess the specifics of individual circumstances, and results may vary based on context and
individual needs.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.
Create an Account
Create your FREE account to receive personalised announcements, watchlists, market updates, investment insights and new features.
Personalise your experience
Tell us a little about yourself to receive personalised content, announcements and relevant investment opportunities.